Plain-English translation of NCT06870500 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is investigating a specific genetic variation (a small difference in your genes) in people with psoriasis or psoriatic arthritis to understand how it affects how well patients respond to , a medication that has been used successfully to treat these conditions for decades. By studying this gene in Egyptian patients, researchers hope to learn why some people improve with this medication while others may not respond as well.
is a proven, affordable treatment for moderate to severe psoriasis and psoriatic arthritis, but it doesn't work equally well for everyone. Understanding the genetic factors that influence treatment response could help doctors predict which patients will benefit most from this medication and potentially improve care for people with these painful, long-term skin and joint conditions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be asked to provide a blood sample that researchers will test for the specific genetic variation they are studying. You will also be grouped with other participants based on your diagnosis (psoriasis alone, psoriasis with arthritis, or healthy volunteer), and the researchers will collect information about your condition and how you respond to treatment. The study is recruiting 50 participants total across these three groups.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Egypt